P****D
发帖数: 11146 | 1 学校群发的邮件。要求7-10年工作经验，版上绝大多数同学是没戏了。但是有志于从事
此行业的同学们，可以看看它的工作要求，然后决定自己的努力方向，比如学习什么软
件什么课程等等。
Date: February 25, 2011
Location: Northfield, Illinois
Title: Healthcare Outcomes Analyst
Position Purpose Statement
The Healthcare Outcomes Analyst is responsible for analyzing clinical and
economic outcomes for Pharos's customers, and for developing analytical
systems and processes to provide continuous measurement of customer results
and business processes. The Healthcare Outcomes Analyst is also re... 阅读全帖 |
|
d********9
发帖数: 598 | 2 -----------------------------------
The Coming Collapse: “We Can Buy Time, But We Can’t Change the Outcome”
Western rogue civilization is basically doomed, the president of the Ayn
Rand Institute says
--------------------------------
http://finance.yahoo.com/blogs/daily-ticker/coming-collapse-buy
The Ayn Rand Institute held its annual "Atlas Shrugged Revolution" dinner
Thursday night in New York City.
In attendance were a number of financial luminaries and hedge fund managers,
including Peter Sc... 阅读全帖 |
|
d**b
发帖数: 1286 | 3 GlaxoSmithKline is looking for a Manager, Applied Outcomes & Analysis.
This is a direct hire, full time opportunity.
Requisition ID: 49457
Apply online at: http://jobsearch.gsk.com/
Search for Requisition ID: 49457 or Applied Outcomes.
Details:
Description: Health outcomes analytic position within Managed Care
Division of GlaxoSmithKline. Emphasis on analytics through SAS
programming to support managed care including third party payment,
government (payer, research organizations, etc.) and |
|
h*********i
发帖数: 494 | 4 outcome report就是PI从co-PI（如果有的话）手里收outcome report，然后弄一起，
submit |
|
R******o
发帖数: 83 | 5 大概是这样的数据：
ID Time Group Outcome
1 1 A Y
2 1 A N
3 1 A N
4 1 B Y
5 1 B N
6 1 B N
7 2 A Y
8 2 A N
9 2 A Y
10 2 B N
11 2 B N
....
....
Proc glimmix data=...;
Class group?
model Outcome=Group ？
Random ID ? or Random intercept/ subject=ID ??
Random time/subject=ID Rside?
Run;
我实在很糊涂，不明白怎样同时分析group effect 和 time effect，应不应该把time
放到Model 里面。
应该是Random ID 还是 Subject=ID，两种得到的结果不一样。
而且好像 用 Rside，就必须把time 放到 Class 后面。 |
|
h******y
发帖数: 3501 | 6 这个到底是做什么的？
这４个词分开来看我都很MATCH，合在一起就不知道了。
HEALTH：目前在医院上班，符合吧
ECONOMICS：有ECON MS DEGREE
OUTCOMES：TITLE就是OUTCOMES ANALYST
RESEARCH：和MD一起发PAPER，算RESEARCH吧。 |
|
S********a
发帖数: 359 | 7 outcome变量Y＝1，2，3，4， 想建一个unadjusted logistic regression for x, x
是一个连续型的数，用什么SAS procedure呢？
logistic reg的outcome是要在0，1间的，这个很象，但是level更多,还是用logistic
吗？什么特别的option 或者 link 吗？
谢谢 |
|
n***p
发帖数: 508 | 8 Have anyone used time series independent variables to predict a binary
outcome? what methodology are you using.
for example, I have 12 month time series for each independent variable, and
at month 13, I have a binary outcome.
I want to keep the time series, and I do not want to transform the variables
like in the way people do general credit score card development.
please suggest, thanks |
|
S*******u
发帖数: 727 | 9 我想请教一个问题:
我在做LOGISTIC PREDICTION. 我有CONTINOUS 的 INDEPENDENT PREDICTOR,我要TEST
这个CONTINUOUS PREDICTOR 是否与BINARY OUTCOME 有RELATED.但是我不想把
CONTINUOUS 的VARAIBLE 变成CATEGORICAL,用哪个TEST 测CONTINUOUS VARIABLE 与
BINARY OUTCOME 的相关性?
谢谢了 |
|
b******2
发帖数: 654 | 10 两个group,用propensity score matching得到 500 病人， 1000个健康人， 应该用什
么test 比较matched group的 continuous and binary outcomes?
1：1 propensity score matching will need to use paired t-test/signed rank
test for continuous, McNemar for binary outcome.对1:2 matched ， 好像不能用
。 谢谢！ |
|
x******n
发帖数: 9057 | 11 标题党啊，expected average outcome和outcome是一回事么 |
|
G******f
发帖数: 16223 | 12 use the expected average outcome to predict the outcome mah |
|
L***s
发帖数: 9258 | 13 恭你个头啊！outcome report，都干完了才写的。老的。 |
|
G***G
发帖数: 16778 | 14 health outcomes and policies方向有前景吗？
申请grants容易吗？谢谢！ |
|
g******u
发帖数: 250 | 15 For us that haven't heard anything, it is overwhelming to follow every post
regarding the lottery outcome. Could we have the following 4 top-placed
posts
1, Vermont, PP;
2, Vermont, Non-PP;
3, California, PP;
4, California, Non-PP;
dedicated to tracking the latest happenings in each category, if any.
Many thanks! |
|
Z*******5
发帖数: 178 | 16 请感兴趣的朋友来简历到c************[email protected].
谢谢
Outcome Research Position
Roles and Responsibilities:
Prepare, verify, and manage research data sets from administrative
health insurance claims, electronic medical record databases, randomized
clinical trials, or other sources as per provided specifications.
Perform ad-hoc queries, statistical analysis, modeling, and reporting
using SAS.
Conduct analytic quality assurance procedures and creation of final
deliverables.
Develop SAS macro lib... 阅读全帖 |
|
m********0
发帖数: 165 | 17 本人美国博士毕业，在业内大医疗保险公司工作
博士期间发表文章9篇，绝大多数为业界一流期刊。
因为以前一直没有攒review，现在手里只有8篇给value in health的审稿。
ld明年毕业，希望能尽快办理eb1a
求health outcomes，drug safety,药物流行病学、药物经济学、生统方面审稿机会,可
以提供详细CV
谢谢！ |
|
m********0
发帖数: 165 | 18 本人美国博士毕业，在业内大医疗保险公司工作
博士期间发表文章9篇，绝大多数为业界一流期刊。
因为以前一直没有攒review，现在手里只有8篇给value in health的审稿。
ld明年毕业，希望能尽快办理eb1a
求health outcomes，药物流行病学、药物经济学、生统方面审稿机会
谢谢！ |
|
m********0
发帖数: 165 | 19 求审稿机会：药物安全、health outcomes、药品价格、流行病学、cancer、obesity、
asthma
本人美国博士毕业，业内大公司工作，已发表英文论文9篇，审稿11次
有意帮忙的朋友麻烦站内信我，可以提供详细CV。
谢谢！ |
|
m********0
发帖数: 165 | 20 准备9月底10月初提交EB1A申请，现有审稿21篇（有impact factor的只有12篇）。本人
在NSC区，律师说最好能再攒几篇有impact factor的审稿。
本人已经给Value in Health, Journal of Managed Care Pharmacy, Drug safety,
Journal of Preventive Medicine, BMJ Open, Statistical Methods in Medical
Research等杂志审过稿。审稿非常认真，速度快。
求审稿机会：药物安全、health outcomes、药品价格、流行病学、Bio statistics,
cancer、obesity、asthma
本人美国博士毕业，业内大公司工作，已发表英文论文9篇，审稿21次。
有意帮忙的朋友麻烦站内信我，可以提供详细CV。
唯一要求就是要求杂志有impact factor，非常感谢大家的帮助！ |
|
j*****k
发帖数: 1198 | 21
//after this line s1=s2
//so outcome is world! world!
Am I right? |
|
G***G
发帖数: 16778 | 22 health outcomes and policies方向有前景吗？
申请grants容易吗？谢谢！ |
|
b****b
发帖数: 199 | 23 【 以下文字转载自 JobHunting 讨论区 】
发信人: bibbub (道成肉身), 信区: JobHunting
标 题: Job: Consultant in Pharmacoeconomics and Outcomes Research
发信站: BBS 未名空间站 (Wed Oct 8 20:05:41 2008)
We are seeking highly talented candidates with strong quantitative
background to join in our health care practice. Please see job posting at
http://jobs.amstat.org/jobdetail.cfm?job=3000455
The position is continuously open for long term. For further information,
please go to http://www.analysisgroup.com |
|
h****r
发帖数: 9 | 24 A dice is tossed K times (K is a constant): P(X_k = i)=p_i, i=1~6 (when even
, p_i=1/6). The outcomes are summed up. Y=\sum_{k}X_k. What's the pmf of Y?
Is this a trival problem? |
|
x*****i
发帖数: 22 | 25 Can anyone recommed some references for competing risks models with
correlated outcomes? Thank you. |
|
s********r
发帖数: 51 | 26 本人目前在南方一所3流大学读经济学的MS,由于工作很不好找.计划申请MPH,选择其中
的Outcome Research 或者 Cost Effectiveness Analysis的方向. 我没有任何的医学
或制药的背景,只有经济学背景.请问选这两个方向读MPH以后好不好在药厂,或者医疗行
业找到相关的工作. 谢谢. |
|
F*****y
发帖数: 100 | 27 outcome research is a good major. An expanding area in the industry. |
|
s*r
发帖数: 2757 | 28 outcome research 和phase 4有啥异同点? |
|
x*****i
发帖数: 22 | 29 Can anyone recommend some references for competing risks models with
correlated outcomes? Thank you. |
|
b****b
发帖数: 199 | 30 【 以下文字转载自 JobHunting 讨论区 】
发信人: bibbub (道成肉身), 信区: JobHunting
标 题: Job: Consultant in Pharmacoeconomics and Outcomes Research
发信站: BBS 未名空间站 (Wed Oct 8 20:05:41 2008)
We are seeking highly talented candidates with strong quantitative
background to join in our health care practice. Please see job posting at
http://jobs.amstat.org/jobdetail.cfm?job=3000455
The position is continuously open for long term. For further information,
please go to http://www.analysisgroup.com |
|
x**7
发帖数: 341 | 31 a longitudinal outcome classified into 7 mutually exclusive categories.
thanks for any suggestions |
|
x**7
发帖数: 341 | 32 多谢2位！
categorized outcome 可以用 mixed model 吗？ |
|
S******y
发帖数: 1123 | 33 I am comparing kknn and logistic regression for binary outcome prediction -
For kknn, I can do -
kknn_<-kknn(out_come ~ age + gender , learn_, valid_)
fit<-fitted(kknn_)
table(valid_$out_come, fit)
to get validation results in cross-tabulation. |
|
b*********w
发帖数: 34 | 34 我本身是生统，现在有outcome research 和pharmaeconomics的机会，是temporary的
，在组里还是做data analysis.但是我对这个方向不太了解，有没有jms做过这个方向
哇？以后的前景如何？我知道和clinical trials 没什么关系，我还是想做clinical
trials，以后能去pharmaceutical的，不知道做这个对以后有没有什么帮助。谢谢！ |
|
h*e
发帖数: 10233 | 35 啊，看了看要求,什么outcome,intervention,cohort,ICD-9,DRG的，真是好熟悉的词呀
。当年在Nursing school里干的就是这些活。嗯！ |
|
k*********g
发帖数: 212 | 36 求电子书Quality of Life Outcomes in Clinical Trials and Health-Care
Evaluation: A Practical Guide to analysis and interpretationthank you very
much
there is big BAOZI |
|
S*******u
发帖数: 727 | 37 是这样的.
Object: Test whether age is related to the binary outcome(Coupon RedemptionY
/N)?
就是TEST 是否使用COUPON 是否与AGE 有关.
我不想把AGE 变成AGE GROUP( 18-28, 28-38, 39-49....),如果变成AGE GROUP, 我可
用CHI-SQUARE TEST.
但是我想用AGE 是 CONTINUOUS 的.比如(20,12, 22, 23.....60..)但是不知道该用哪
个TEST THE RELATED OR NOT RELATED? |
|
m****o
发帖数: 467 | 38 我一直都是用SAS LOGISTIC regression做binary outcome 的数据分析 但这里有个问
题就是无论是LOGISTIC， GENMOD， GLIMMIX， 还是 NLIN， NLMIED，HPNLMOD， 都需
要LINK FUNCTION， 譬如 LOGIT， PROBIT， LOGLOG， CLOGLOG。貌似SEMI－
PARAMETRIC的分析不需要知道DISTRIBUTION 这是不是就说不需要LINK FUNCTION？要用
啥软件做这样的数据分析，R的NP PACKAGE行不行？SEMI－PARAMETRIC REGRESSION里里
有个SINGLE INDEX MODEL能用不？还是有其他更好的方法？
非常非常非常感谢！！！ |
|
B*****m
发帖数: 679 | 39 ft.... i think there are more sophisticated models that predict outcomes. |
|
W*****s
发帖数: 684 | 40 要求卫生部全面禁止肖氏术及请求最高法院依法责令地方法院受理相关案件的信访函
探索性的研究，其安全性、有效性的循证医学证据不足，肖传国的研究存在“极大的缺
陷”。除非有令人信服的论据和数据来验证这一治疗方法，否则不适当地、仓促地在患
者身上和医疗界推广应用此手术会有极大危险。 根据卫生部《医疗技术临床应用
管理办法》规定：“医疗技术分为三类：……第三类医疗技术是指具有下列情形之一，
需要卫生行政部门加以严格控制管理的医疗技术：（一）涉及重大伦理问题；（二）高
风险；（三）安全性、有效性尚需经规范的临床试验研究进一步验证；（四）需要使用
稀缺资源；（五）卫生部规定的其他需要特殊管理的医疗技术”；“属于第三类的医疗
技术首次应用于临床前，必须经过卫生部组织的安全性、有效性临床试验研究、论证及
伦理审查”；“ 第二类医疗技术和第三类医疗技术临床应用前实行第三方技术审核制
度”；“ 省级卫生行政部门负责审定第二类医疗技术的临床应用。卫生部负责审定第
三类医疗技术的临床应用”；“ 医疗机构在医疗技术临床应用过程中出现下列情形之
一的，应当立即停止该项医疗技术的临床应用，并向核发其《医疗机构执业... 阅读全帖 |
|
p**********n
发帖数: 1470 | 41 Those who say the American law practice is not evil must be blind.
Results
At Bruno Law Offices, we are dedicated to providing experienced, aggressive
legal representation for individuals who have been accused of a crime or
have been hurt by the negligent actions of another party. We have decades of
experience handling such criminal, personal injury, workers’ compensation,
and DUI cases. If you or someone you love needs dedicated legal assistance,
contact us at (217) 328-6000.
Practice Area: Fel... 阅读全帖 |
|
v**********m
发帖数: 5516 | 42 http://m.f1000research.com/articles/3-291/v1
波士顿地区的千老联合会的报告，文章提到的问题非常典型和深刻，该文已经在圈内得
到了包括大佬们的极大肯定(恐惧)。
OPINION ARTICLE
Shaping the Future of Research: a perspective from junior scientists[v1;
ref status: approved 1, approved with reservations 1,http://f1000r.es/4ug]
Gary S. McDowell1*, Kearney T. W. Gunsalus2*, Drew C. MacKellar3, Sarah A.
Mazzilli4, Vaibhav P. Pai1, Patricia R. Goodwin5, Erica M. Walsh6, Avi
Robinson-Mosher7, Thomas A. Bowman8, James Kraemer9, Marcella L. Erb10, Eldi
Schoenfeld1... 阅读全帖 |
|
a***r
发帖数: 420 | 43 做助教，本来只是想做个教学demo，show一下confounding 和 partial correlation的
概念，结果纠结了。。。
我simulate了三个variable: outcome, var1, var2。其中outcome是binary; var1 有
三个category 1/2/3; var2 continuous。三者之间都有correlation，我的目的是show
var2对var1和outcome之间association的confounding
R code如下：
> table(outcome)
outcome
0 1
52 48
> table(var1)
var1
0 1 2
19 44 37
> summary(var2)
Min. 1st Qu. Median Mean 3rd Qu. Max.
0.002583 0.053960 0.105000 0.122800 0.184200 0.392700
> cor(outcome,var1)
[1] 0.2854862
> cor(outcome,var... 阅读全帖 |
|
发帖数: 1 | 44 07 Nov 2019
Just as the clamor about Biogen’s seeking FDA approval for aducanumab with
one positive Phase 3 trial started to die down, a Chinese company garnered a
regulatory thumbs-up for its drug, also with one Phase 3 trial. On November
2, Shanghai Green Valley Pharmaceuticals announced that China’s National
Medical Product Administration (NMPA) had conditionally approved GV-971, aka
oligomannate, for the treatment of mild to moderate Alzheimer’s disease.
Full approval, expected to come in sp... 阅读全帖 |
|
|
t********r
发帖数: 4908 | 46 ☆─────────────────────────────────────☆
littleice (家有两宝：狗娃猪仔) 于 (Thu Jul 29 16:58:01 2010, 美东) 提到:
今天去图书馆，偶尔在书架上发现这本书。
positive pushing--how to raise a successful and happy child，by Jim Taylor,
Ph.D.
我一看这个题目就笑了，心说不借来看看，咋对得起推妈的虚名？
看了看目录，貌似还可以。
等我看完了再来汇报。
☆─────────────────────────────────────☆
onlooker11 (onlooker) 于 (Fri Jul 30 15:34:14 2010, 美东) 提到:
看完了没？
,
☆─────────────────────────────────────☆
heleniry (瘦哥胖妹) 于 (Fri Jul 30 15:51:04 2010, 美东) 提到:
等的你读书笔记了。。。
,
☆───────────────... 阅读全帖 |
|
z*********e
发帖数: 10149 | 47 http://www.weidai.com/smart-losers.txt
Given that there is significant existing variation in human intelligence,
it's curious that we are not all much smarter than we actually are.
Besides the well-known costs of higher intelligence (e.g., more energy
use, bigger heads causing more difficult births), it seems that being
smart can be a disadvantage when playing some non-zero-sum games. Here is
one example.
Consider an infinitely repeated game with 2n players, where in each round
all players are r... 阅读全帖 |
|
Y**u
发帖数: 5466 | 48 ☆─────────────────────────────────────☆
Hermes99 (Hermes99) 于 (Thu Oct 20 23:46:31 2011, 美东) 提到:
有贴佛化人生的，我就跟着合一下道化人生。其实，标签是无所谓的。
估计吵架的歇停了。可以开扯了吧。我通常是扯着扯着就扯出灵感了，所以，先感谢参
与。
都说，易有太极，而后是生两仪，两仪再生四象，四象而后生八卦，八卦用来类万物。
俺就以这句圣人总结的话为引子，扯几段，一为阴阳篇，二为类象篇，三为消长篇，四
为变化篇。扯完了，就差不多是偶的世界观。所以，世界观阿，也是很严肃的事情。
肯定有人觉得我是扯。我就行而上的扯扯，行下的也扯扯。
☆─────────────────────────────────────☆
luobing (萝冰) 于 (Fri Oct 21 00:12:43 2011, 美东) 提到:
☆─────────────────────────────────────☆
Hermes99 (Hermes99) 于 (Fri Oct 21 00:17:32... 阅读全帖 |
|
s******y
发帖数: 28562 | 49 我觉得他的文章的意思就是大部分基因的表达程度都和细胞的活跃程度有关，
所以随便乱抓几个都能看出区别来，但是和癌症的机理基本上就是打酱油的关系。
总体意思就是目前的主流方法找出来的marker不能作为推测机理的起点。
他们在faculty 1000上抱怨说他们这篇文章一共投了4年，前后被六个
顶级杂志据了（他们直接点名的几家估计是对他们态度最糟糕的，哈哈哈）
这里是他们在PLoS Comp Biol 发表的文章的摘要。
Bridging the gap between animal or in vitro models and human disease is
essential in medical research. Researchers often suggest that a biological
mechanism is relevant to human cancer from the statistical association of a
gene expression marker (a signature) of this mechanism, that was d... 阅读全帖 |
|
s******y
发帖数: 28562 | 50 我觉得他的文章的意思就是大部分基因的表达程度都和细胞的活跃程度有关，
所以随便乱抓几个都能看出区别来，但是和癌症的机理基本上就是打酱油的关系。
总体意思就是目前的主流方法找出来的marker不能作为推测机理的起点。
他们在faculty 1000上抱怨说他们这篇文章一共投了4年，前后被六个
顶级杂志据了（他们直接点名的几家估计是对他们态度最糟糕的，哈哈哈）
这里是他们在PLoS Comp Biol 发表的文章的摘要。
Bridging the gap between animal or in vitro models and human disease is
essential in medical research. Researchers often suggest that a biological
mechanism is relevant to human cancer from the statistical association of a
gene expression marker (a signature) of this mechanism, that was d... 阅读全帖 |
|
